Dr. Rebecca Roediger is a transplant hepatologist and the medical director of the Center for Alcohol and Liver Medicine (CALM) at Weill Cornell Medicine. She specializes in the management of patients with liver diseases, including autoimmune liver disease, viral hepatitis B and C, alcohol-associated liver disease, metabolic associated fatty liver, and liver cancer. She sees patients with end-stage liver disease (cirrhosis) and evaluates those who need liver transplantation. She provides medical care to patients before and after liver transplantation, including management of immunosuppression. She has a special interest in the care of patients with alcohol-associated liver disease and alcohol use disorder.

She received her bachelor of arts degree from Stanford University and her medical degree from Weill Cornell Medical College. She completed her internal medicine residency at the Mount Sinai Hospital, and her gastroenterology and transplant hepatology fellowships at Washington University in St. Louis.

She previously served as the founding medical director of the multidisciplinary alcohol-associated liver disease program at Montefiore Medical Center, which integrated hepatology, psychiatry, psychology, social work, pharmacy, nutrition, and peer recovery support for patients throughout the liver transplant process. She joined Weill Cornell Medicine as Assistant Professor of Medicine to lead CALM, a multidisciplinary clinic where patients receive liver care and alcohol use disorder care together in the same clinic. She is a founding member of the Consortium for Alcohol-related Recovery and Engagement in Advanced Liver Disease (CARE-ALD), a national group of medical centers studying how integrated alcohol-associated liver disease clinics can best improve patient outcomes. Her work focuses on improving access to addiction treatment and liver transplantation and on long-term outcomes for patients with alcohol-associated liver disease.